Antitrust
More on Antitrust
Boulder, C.O. – On Friday, January 17th at 10 AM, the House Judiciary Subcommittee on Antitrust, Commercial and Administrative Law will hold a field hearing in Boulder, CO to examine the state of competition in the digital marketplace. The hearing, entitled Online Platforms and Market Power, Part 5: Competitors in the Digital Economy, is the fifth hearing in the Subcommittee's series on dominant platforms. The Subcommittee will hear from top executives of companies with concerns about the rise of market power and anticompetitive conduct online.
|
Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) and Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) sent a letter to Federal Communications Commission (FCC) Chairman Ajit Pai concerning the troubling lack of transparency, and an apparent lack of appropriate process, leading up to the FCC's approval of the T-Mobile/Sprint merger. |
|
Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 5133, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019: |
|
Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019: |
|
Today, House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) to prohibit pharmaceutical companies from engaging in anticompetitive "product hopping." The bill is scheduled to be marked up in the Judiciary Committee on Wednesday. |